177 related articles for article (PubMed ID: 27832631)
21. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-130b functions as a tumor suppressor by regulating RUNX3 in epithelial ovarian cancer.
Paudel D; Zhou W; Ouyang Y; Dong S; Huang Q; Giri R; Wang J; Tong X
Gene; 2016 Jul; 586(1):48-55. PubMed ID: 27048832
[TBL] [Abstract][Full Text] [Related]
23. Potential role of miR-29b in modulation of Dnmt3a and Dnmt3b expression in primordial germ cells of female mouse embryos.
Takada S; Berezikov E; Choi YL; Yamashita Y; Mano H
RNA; 2009 Aug; 15(8):1507-14. PubMed ID: 19509302
[TBL] [Abstract][Full Text] [Related]
24. Anticancer role of MUC1 aptamer-miR-29b chimera in epithelial ovarian carcinoma cells through regulation of PTEN methylation.
Dai F; Zhang Y; Zhu X; Shan N; Chen Y
Target Oncol; 2012 Dec; 7(4):217-25. PubMed ID: 23179556
[TBL] [Abstract][Full Text] [Related]
25. MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer.
Zhang Y; Zhao FJ; Chen LL; Wang LQ; Nephew KP; Wu YL; Zhang S
Oncotarget; 2014 Dec; 5(23):12291-303. PubMed ID: 25460499
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-302b suppresses human epithelial ovarian cancer cell growth by targeting RUNX1.
Ge T; Yin M; Yang M; Liu T; Lou G
Cell Physiol Biochem; 2014; 34(6):2209-20. PubMed ID: 25562167
[TBL] [Abstract][Full Text] [Related]
27. miR-29s inhibit the malignant behavior of U87MG glioblastoma cell line by targeting DNMT3A and 3B.
Xu H; Sun J; Shi C; Sun C; Yu L; Wen Y; Zhao S; Liu J; Xu J; Li H; An T; Zhou X; Ren L; Wang Q; Yu S
Neurosci Lett; 2015 Mar; 590():40-6. PubMed ID: 25625222
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B.
Fabbri M; Garzon R; Cimmino A; Liu Z; Zanesi N; Callegari E; Liu S; Alder H; Costinean S; Fernandez-Cymering C; Volinia S; Guler G; Morrison CD; Chan KK; Marcucci G; Calin GA; Huebner K; Croce CM
Proc Natl Acad Sci U S A; 2007 Oct; 104(40):15805-10. PubMed ID: 17890317
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-520g promotes epithelial ovarian cancer progression and chemoresistance via DAPK2 repression.
Zhang J; Liu L; Sun Y; Xiang J; Zhou D; Wang L; Xu H; Yang X; Du N; Zhang M; Yan Q; Xi X
Oncotarget; 2016 May; 7(18):26516-34. PubMed ID: 27049921
[TBL] [Abstract][Full Text] [Related]
30. S100A7 Regulates Ovarian Cancer Cell Metastasis and Chemoresistance Through MAPK Signaling and Is Targeted by miR-330-5p.
Lin M; Xia B; Qin L; Chen H; Lou G
DNA Cell Biol; 2018 May; 37(5):491-500. PubMed ID: 29485916
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma.
Zou YT; Gao JY; Wang HL; Wang Y; Wang H; Li PL
Genet Mol Res; 2015 Jul; 14(3):8766-77. PubMed ID: 26345808
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of microRNA-196b Accelerates Invasiveness of Cancer Cells in Recurrent Epithelial Ovarian Cancer Through Regulation of Homeobox A9.
Chong GO; Jeon HS; Han HS; Son JW; Lee YH; Hong DG; Park HJ; Lee YS; Cho YL
Cancer Genomics Proteomics; 2017; 14(2):137-141. PubMed ID: 28387653
[TBL] [Abstract][Full Text] [Related]
33. Methylation-associated Has-miR-9 deregulation in paclitaxel- resistant epithelial ovarian carcinoma.
Li X; Pan Q; Wan X; Mao Y; Lu W; Xie X; Cheng X
BMC Cancer; 2015 Jul; 15():509. PubMed ID: 26152689
[TBL] [Abstract][Full Text] [Related]
34. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
[TBL] [Abstract][Full Text] [Related]
35. MiR-494 Inhibits Epithelial Ovarian Cancer Growth by Targeting c-Myc.
Yuan J; Wang K; Xi M
Med Sci Monit; 2016 Feb; 22():617-24. PubMed ID: 26908019
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic control of EMT/MET dynamics: HNF4α impacts DNMT3s through miRs-29.
Cicchini C; de Nonno V; Battistelli C; Cozzolino AM; De Santis Puzzonia M; Ciafrè SA; Brocker C; Gonzalez FJ; Amicone L; Tripodi M
Biochim Biophys Acta; 2015 Aug; 1849(8):919-29. PubMed ID: 26003733
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-127-3p acts as a tumor suppressor in epithelial ovarian cancer by regulating the BAG5 gene.
Bi L; Yang Q; Yuan J; Miao Q; Duan L; Li F; Wang S
Oncol Rep; 2016 Nov; 36(5):2563-2570. PubMed ID: 27571744
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic Regulation of miR-29s Affects the Lactation Activity of Dairy Cow Mammary Epithelial Cells.
Bian Y; Lei Y; Wang C; Wang J; Wang L; Liu L; Liu L; Gao X; Li Q
J Cell Physiol; 2015 Sep; 230(9):2152-63. PubMed ID: 25656908
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA CCAT1 promotes metastasis and poor prognosis in epithelial ovarian cancer.
Cao Y; Shi H; Ren F; Jia Y; Zhang R
Exp Cell Res; 2017 Oct; 359(1):185-194. PubMed ID: 28754469
[TBL] [Abstract][Full Text] [Related]
40. MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression.
Tang W; Jiang Y; Mu X; Xu L; Cheng W; Wang X
Cell Signal; 2014 Jul; 26(7):1420-6. PubMed ID: 24607788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
